Biden Administration Takes Action to Improve Paxlovid Affordability
In a push to make COVID-19 treatment more accessible, the Biden administration is working with pharmacies and Pfizer to ensure Paxlovid is affordable for all.
- Health and Human Services Secretary Xavier Becerra met with CEOs of major pharmacies to discuss Paxlovid's affordability.
- Paxlovid, a COVID-19 antiviral, is underutilized due to its high cost and hesitancy among providers to prescribe it.
- The federal government negotiated with Pfizer to make Paxlovid free for individuals on Medicare and Medicaid through the end of 2024.
- Uninsured individuals can access Paxlovid for free through 2028, with a copay assistance program available for those with commercial insurance.
- Reports indicate patients have been charged high co-pays or even the full price for Paxlovid, prompting administration action.